Sign Up to Receive Your Personalised Learning Resources

JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
CE/CME ACCREDITED
Key data in gastrointestinal cancer: ESOPEC, TRANSMET, COLLISION, ARC-9
Shaping the future of cancer surgery: An interview with Professor Geerard Beets
Q&A with Dr Benjamin Weinberg: Understanding rare GI cancers (small bowel, appendix and anal cancer)
Updates in BCMA-directed therapies in multiple myeloma from ASH 2024
CE/CME ACCREDITED
Trending at #ASCO2024
Focused insights: Data implications of ADCs in NSCLC treatment
CE/CME ACCREDITED
Advances in Targeting KRAS G12C in Gastrointestinal Malignancies: Focus on KRAS G12C Inhibitors
Quad Pro Quo: Deciphering the role of anti-CD38 quadruplets in newly diagnosed multiple myeloma (NDMM)
Sponsored content
CDK4/6 inhibitors in HR+ HER2- EBC: Expert discussions on patient identification, efficacy, and adherence
Sponsored content
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
CE/CME ACCREDITED
Key data in gastrointestinal cancer: ESOPEC, TRANSMET, COLLISION, ARC-9
Shaping the future of cancer surgery: An interview with Professor Geerard Beets
Q&A with Dr Benjamin Weinberg: Understanding rare GI cancers (small bowel, appendix and anal cancer)
Updates in BCMA-directed therapies in multiple myeloma from ASH 2024
CE/CME ACCREDITED
Trending at #ASCO2024
Focused insights: Data implications of ADCs in NSCLC treatment
CE/CME ACCREDITED
Advances in Targeting KRAS G12C in Gastrointestinal Malignancies: Focus on KRAS G12C Inhibitors
Quad Pro Quo: Deciphering the role of anti-CD38 quadruplets in newly diagnosed multiple myeloma (NDMM)
Sponsored content
CDK4/6 inhibitors in HR+ HER2- EBC: Expert discussions on patient identification, efficacy, and adherence
Sponsored content
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
CE/CME ACCREDITED
Key data in gastrointestinal cancer: ESOPEC, TRANSMET, COLLISION, ARC-9
Shaping the future of cancer surgery: An interview with Professor Geerard Beets
Q&A with Dr Benjamin Weinberg: Understanding rare GI cancers (small bowel, appendix and anal cancer)
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Elisabetta Zanon appointed as Chief Executive Officer of the European Cancer Organisation
View
Foreword – touchREVIEWS in Oncology & Haematology, Volume 20, Issue 2, 2024
View
Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma: From optimal sequencing to shared decision-making
View
Transarterial chemoembolization with lenvatinib and pembrolizumab showed improvement in progression-free survival for hepatocellular carcinoma
View
Project Cure CRC Awards Nearly $5 Million to Accelerate Advancements in Care
View
PARP inhibitors for metastatic castration-resistant prostate cancer: Enhancing patient–practitioner conversations
View
Trifluridine/Tipiracil and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer
View
FUTURE LEADERS: Shaping the future of melanoma and sarcoma with Dr Rodrigo Munhoz
View
Shaping the future of cancer surgery: An interview with Professor Geerard Beets
View
Niraparib as first-line maintenance treatment in ovarian cancer
View
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGY
Sign me up!